-
-process and release testing of GMP Manufacturing and analytical development for cellular immunotherapy products. This is a fast-paced lab involved in cutting edge technology, research and clinical cellular
-
, shaping the future of medicine through cutting-edge research. The QC team for Cellular and Gene Therapy Operations seeks a skilled Quality Control Manager to oversee in-process and release testing for GMP
-
in to IRB clinical trials. Assess and document signs and symptoms of illness, reactions to treatment, changes in physical or psychological condition and general appearance in accordance with the IRB
-
to the research subjects, participates in the informed consent process, enrolls, and coordinates care of subjects in compliance with protocol requirements. The CRN may provide teaching on investigational agents
-
data reporting requirements. Review and process invoices from sub-sites. Regulatory Responsibilities for Participating Sites: Manage deviation, adverse event, and unanticipated problem reporting. Systems
-
process to ensure compliance with regulations. Conduct pre-reviews of submissions, ensuring completeness and compliance, coordinating timely reviews, preparing committee minutes, and issuing action notices
-
consent documents · Coordinate responses during the protocol approval process, interfacing with internal stakeholders Your qualifications should include: · Master's degree or Bachelor's degree
-
-process and release testing of GMP Manufacturing and analytical development for cellular immunotherapy products. This is a fast-paced lab involved in cutting edge technology, research and clinical cellular
-
. The successful candidate: Hours: Part time, Thursdays only (12hrs per week) Performs all tasks related to the EHR admission/discharge process of outpatient and inpatient visits. Performs accurate patient
-
process to ensure compliance with regulations. Conduct pre-reviews of submissions, ensuring completeness and compliance, coordinating timely reviews, preparing committee minutes, and issuing action notices